IV Dosing, BSA-Based
Uses body surface area to calculate an individualized intravenous drug dose.
g/sq.mmg/sq.mmcg/sq.m
g/mLmg/mLmcg/mL
sq.m
Indicações de Uso
Use for IV cytotoxic chemotherapy and selected agents where exposure correlates with body size, providing a practical surrogate for drug clearance. Clinically useful for full weight‑based dosing in obese adults to avoid underdosing (ASCO guideline 1 [Level I evidence]). Offers standardized starting doses when pharmacokinetic data are limited, though BSA poorly reduces interpatient PK variability for most drugs (JNCI PK analysis, 1650 pts 2 [Level II evidence]).
Insights e Precauções
Use full actual‑weight BSA for adults; any standard formula is acceptable, as no method improves accuracy 1 [Level I evidence].
- Avoid dose capping unless mandated; underdosing worsens outcomes in obese patients.
- Extremes of size: BSA does not reliably predict clearance and may misdose drugs with narrow therapeutic windows.
- Children <6 y: avoid BSA—use mg/kg to reduce toxicity 2 [Level III evidence].
- Consider PK‑guided strategies when available.